JAZZ PHARMACEUTICALS PLC's ticker is and the CUSIP is G50871955. A total of 3 filers reported holding JAZZ PHARMACEUTICALS PLC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $458,939 | -4.7% | 4,300 | +7.5% | 0.00% | 0.0% |
| Q1 2024 | $481,680 | -14.9% | 4,000 | -13.0% | 0.00% | +100.0% |
| Q4 2023 | $565,800 | -5.0% | 4,600 | 0.0% | 0.00% | -50.0% |
| Q3 2023 | $595,424 | +4703.0% | 4,600 | +4500.0% | 0.00% | – |
| Q2 2023 | $12,397 | -99.8% | 100 | -99.8% | 0.00% | -100.0% |
| Q4 2022 | $7,344,191 | +6.0% | 46,100 | -11.3% | 0.02% | +21.4% |
| Q3 2022 | $6,931,000 | -14.6% | 52,000 | 0.0% | 0.01% | +7.7% |
| Q2 2022 | $8,113,000 | -5.2% | 52,000 | -5.5% | 0.01% | +62.5% |
| Q1 2022 | $8,562,000 | -39.2% | 55,000 | -50.2% | 0.01% | -27.3% |
| Q4 2021 | $14,078,000 | -1.6% | 110,500 | +0.5% | 0.01% | -26.7% |
| Q3 2021 | $14,310,000 | -36.5% | 109,900 | -13.3% | 0.02% | -44.4% |
| Q2 2021 | $22,525,000 | +68157.6% | 126,800 | +63300.0% | 0.03% | – |
| Q1 2021 | $33,000 | -99.8% | 200 | -99.8% | 0.00% | -100.0% |
| Q4 2020 | $13,749,000 | +959.2% | 83,300 | +815.4% | 0.02% | +500.0% |
| Q3 2020 | $1,298,000 | +370.3% | 9,100 | +264.0% | 0.00% | +300.0% |
| Q2 2020 | $276,000 | +10.8% | 2,500 | 0.0% | 0.00% | -50.0% |
| Q1 2020 | $249,000 | -88.8% | 2,500 | -83.2% | 0.00% | -86.7% |
| Q4 2019 | $2,224,000 | -22.2% | 14,900 | -33.2% | 0.02% | -34.8% |
| Q3 2019 | $2,858,000 | +138.6% | 22,300 | +165.5% | 0.02% | +109.1% |
| Q2 2019 | $1,198,000 | -47.0% | 8,400 | -46.8% | 0.01% | -56.0% |
| Q1 2019 | $2,259,000 | +279.7% | 15,800 | +229.2% | 0.02% | +400.0% |
| Q4 2018 | $595,000 | -70.5% | 4,800 | -60.0% | 0.01% | -68.8% |
| Q3 2018 | $2,018,000 | -46.0% | 12,000 | -44.7% | 0.02% | -50.0% |
| Q2 2018 | $3,739,000 | +698.9% | 21,700 | +600.0% | 0.03% | +540.0% |
| Q1 2018 | $468,000 | -93.7% | 3,100 | -94.4% | 0.01% | -90.6% |
| Q4 2017 | $7,487,000 | +250.7% | 55,600 | +280.8% | 0.05% | +178.9% |
| Q3 2017 | $2,135,000 | -20.2% | 14,600 | -15.1% | 0.02% | -32.1% |
| Q2 2017 | $2,675,000 | -38.6% | 17,200 | -42.7% | 0.03% | -45.1% |
| Q1 2017 | $4,354,000 | +55.4% | 30,000 | +16.7% | 0.05% | +88.9% |
| Q4 2016 | $2,802,000 | -62.7% | 25,700 | -58.5% | 0.03% | -67.1% |
| Q3 2016 | $7,520,000 | +192.4% | 61,900 | +240.1% | 0.08% | +173.3% |
| Q2 2016 | $2,572,000 | -59.3% | 18,200 | -62.4% | 0.03% | -66.3% |
| Q1 2016 | $6,319,000 | +85.7% | 48,400 | +100.0% | 0.09% | +122.5% |
| Q4 2015 | $3,402,000 | -6.5% | 24,200 | -11.7% | 0.04% | -20.0% |
| Q3 2015 | $3,639,000 | +44.5% | 27,400 | +91.6% | 0.05% | +42.9% |
| Q2 2015 | $2,518,000 | -46.2% | 14,300 | -47.2% | 0.04% | -52.7% |
| Q1 2015 | $4,683,000 | -76.8% | 27,100 | -78.1% | 0.07% | -75.7% |
| Q4 2014 | $20,221,000 | -18.7% | 123,500 | -20.3% | 0.30% | -20.4% |
| Q3 2014 | $24,887,000 | +33.8% | 155,000 | +22.5% | 0.38% | +33.9% |
| Q2 2014 | $18,597,000 | +22.6% | 126,500 | +15.6% | 0.29% | +12.2% |
| Q1 2014 | $15,172,000 | +42.0% | 109,400 | +29.6% | 0.26% | +58.4% |
| Q4 2013 | $10,682,000 | +128.6% | 84,400 | +66.1% | 0.16% | +80.9% |
| Q3 2013 | $4,672,000 | -7.5% | 50,800 | -30.9% | 0.09% | -28.2% |
| Q2 2013 | $5,052,000 | – | 73,500 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANE STREET GROUP, LLC | 5,000 | $731,650 | 0.00% |
| SIMPLEX TRADING, LLC | 1,900 | $278 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |